Unilateral serous macular detachment and cystoid macular edema following COVID-19 vaccination: A case report-Reference-Cited by-同舟云学术

Unilateral serous macular detachment and cystoid macular edema following COVID-19 vaccination: A case report

Published:2023-10-24 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Sadr Navid Elmi¹^ORCID,Hariri Ramyar¹^ORCID

Affiliation:

1. Semnan University of Medical Sciences

Abstract

Abstract Objective To report a case of unilateral serous macular detachment accompanying cystoid macular edema following the second dose of vaccination for COVID-19. Methods Case report. Case description : A 67-year-old male presented with progressive vision loss in his left eye, seven days after receiving the second dose of the COVID-19 vaccine (BBIBP-CorV, Sinopharm). Fundus examination and spectral domain optical coherence tomography (SD-OCT) showed serous macular detachment with cystoid macular edema in the left eye. The patient’s best-corrected visual acuity improved dramatically, and macular detachment and cystoid macular edema resolved significantly within ten days, without any treatment. Conclusion Transient serous macular detachment accompanying cystoid macular edema may have an association with Sinopharm COVID-19 vaccination. Despite this, vaccination against COVID-19 is strongly recommended.

Publisher

Research Square Platform LLC

Reference14 articles.

1. Ocular Adverse Events After COVID-19 Vaccination;Ng XL;Ocular immunology and inflammation,2021

2. Association of Ocular Adverse Events With Inactivated COVID-19 Vaccination in Patients in Abu Dhabi;Pichi F;JAMA ophthalmology,2021

3. Rello J, Belliato M, Dimopoulos MA, Giamarellos-Bourboulis EJ, Jaksic V, Martin-Loeches I, et al. Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposium. Anaesthesia, critical care & pain medicine. 2020; 39: 723 – 30.

4. World Health Organization. Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm-7 May 2021. available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_recommendation-BIBP-2021.1.

5. Epidemiology of Macular Edema in Uveitis;Accorinti M;Ocular immunology and inflammation,2019